Article
Integrins and extracellular matrix: a novel mechanism of multidrug resistance
1 Aug 2002
Abstract excerpt
Multidrug resistance remains the major hurdle to successful cancer treatment. Classical mechanisms of multidrug resistance include drug efflux pumps, glutathione-S-transferase upregulation and topoisomerase II-associated multidrug resistance. However, despite extensive research, the clinical relevance of these mechanisms remains unclear and no significant clinical benefit has materialized. Recently, a novel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
